Reckitt Benckiser ploughs £4.5m into Strepsils activity
Reckitt Benckiser (RB) is kick-starting a £4.5m marketing campaign to support the launch of Strepsils sore throat and cough lozenges.
The campaign, created by EuroRSCG, will feature a TV ad supported by radio, digital, outdoor, PR and point-of-sale activity.
The new product contains two antiseptics and a mild local anaesthetic, Levomenthol, which RB claims relieves dry tickly coughs.
The existing Strepsils portfolio includes Strepsils original, Strepsils, orange and vitamin C, Strepsils sugar free and Strepsils honey and lemon.
Refik Oner, category marketing director, Health and Personal Care, RB UK, said: "With 10 Strepsils lozenges sold every second in the chemist channel we saw an opportunity to develop this trusted brand and the category further by combining efficacious multi-symptom relief in a portable lozenge format.
"We are really excited about the new Strepsils Sore Throat and Cough product which we are confident will be highly incremental for the category as it provides consumers with a unique way to manage unpleasant symptoms during the coming winter months".
This article was first published on marketingmagazine.co.uk
- Campaign Marketing Manager EMAP Competitive + Bonus, London (Greater) / London (East), London (Greater)
- Exhibition Designers WRG Live Competitive salary and benefits package dependant upon experience, Manchester, Greater Manchester
- Producer WRG Live Competitve salary and benefits package dependent upon experience, London (Central), London (Greater) / Manchester, Greater Manchester
- Content Manager WRG Live Competitive salary and benefits package, Manchester, Greater Manchester
- Senior Creative Team Purple Consultancy £40000 - £50000 per annum, London
- Martin Sorrell earns 780 times more than average WPP employee
- 3 top tips on how to save an epic social media fail
- Lake Capital rejects demands of Engine's rebel shareholders
- Magazine ABCs: a media agency viewpoint
- Head lice-killing mousse launches in the UK with cartoon campaign
- Facebook's 'Buy' button: a leap too far?